Protective effect on Leishmania major infection of migration inhibitory factor, TNF-α, and IFN-γ, administered orally via attenuated Salmonella typhimurium

Journal of Immunology

Volumn 160, Issue 3, 1998, Pages 1285-1289

  Xu, Damo ^a   McSorley, Stephen J ^a   Tetley, Lawrence ^a   Chatfield, Stephen ^b   Dougan, Gordon ^b   Chan, W Ling ^c   Satoskar, Abhay ^d   David, John R ^d   Liew, Foo Y ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; MIGRATION INHIBITION FACTOR; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN L 929; CONTROLLED STUDY; DELETION MUTANT; DRUG DELIVERY SYSTEM; FEMALE; FOOT PAD; GENE EXPRESSION; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPH NODE CELL; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMID; PRIORITY JOURNAL; PROMASTIGOTE; SALMONELLA TYPHIMURIUM; SPLEEN CELL;

ADMINISTRATION, ORAL; ANIMALS; BACTERIAL VACCINES; DISEASE SUSCEPTIBILITY; FEMALE; INTERFERON TYPE II; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, INBRED BALB C; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PLASMIDS; SALMONELLA TYPHIMURIUM; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, ATTENUATED;

EID: 0031939070     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Cantell, K., S. Hirvonen, L. Pyhala, A. de Reus, and H. Schellekens. 1983. Circulating interferon in rabbits and monkeys after administration of human gamma interferon by different routes. J. Gen. Virol. 64:1823.
2. Carrier, M. J., S. N. Chatfield, G. Dougan, U. T. A. Nowicka, D. O'Callaghan, J. E. Beesley, S. Milano, E. Cillari, and F. Y. Liew. 1992. Expression of human IL-1β in Salmonella typhimurium: a model system for the delivery of recombinant therapeutic proteins in vivo. J. Immunol. 148:1176.
3. Dougan, G., C. E. Hormaeche, and D. J. Maskell. 1987. Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system. Parasite Immunol. 9:151.
4. Hormaeche, C. E. 1991. Live attenuated Salmonella vaccines and their potential as oral combined vaccines carrying heterologous antigens. J. Immunol. Methods 142:113.
5. Tacket, C. O., M. B. Sztein, G. A. Losonsky, S. S. Wasserman, J. P. Nataro, R. Edelman, D. Pickard, G. Dougan, S. N. Chatfield, and M. M. Levine. 1997. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect. Immun. 65:452.
6. Liew, F. Y., and C. A. O'Donnell. 1993. Immunology of leishmaniasis. Adv. Parasitol. 32:161.
7. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
8. Scott, P., P. Natovitz, R. L. Coffman, E. Pearce, and A. Sher. 1988. Immunoregulation of cutaneous leishmaniasis: T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168:1675.
9. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon-gamma or interleukin-4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59.
10. + T cell response. J. Exp. Med. 181:961.
11. Green, S. J., M. S. Meltzer, J. B. Hibbs, and C. A. Nacy. 1990. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144:278.
12. Liew, F. Y., S. Millott, C. Parkinson, R. M. J. Palmer, S. Moncada. 1990. Macrophage killing of Leishmania parasites in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144:4794.
13. Stenger, S., H. Thuring, M. Rollinghoff, and C. Bogdan. 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:783.
14. Scott, P. 1991. IFN-γ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147:3149.
15. - T cells that do not mediate cutaneous DTH. J. Immunol. 132:456.
16. Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater, and N. F. Fairweather. 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Biotechnology 10:888.
17. McSorley, S. J., D. Xu, and F. Y. Liew. 1997. The efficacy of Salmonella strains expressing gp63 using different promoters. Infect. Immun. 65:171.
18. Weiser, W. Y., P. A. Temple, J. S. Witek-Giannotti, H. G. Remold, C. Clark, and J. R. David. 1989. Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc. Natl. Acad. Sci. USA 86:7522.
19. Strugnell, R., G. Dougan, S. Chatfield, I. Charles, N. Fairweather, J. P. Tite, J. L. Li, J. Beesley, and M. Roberts. 1992. Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis. Infect. Immun. 60:3994.
20. Griffiths, G. 1993. Fine Structure Immunocytochemistry. Springer-Verlag, Heidelberg.
21. Tokuyasu, K. T. 1986. Application of cryoultramicrotomy to immunocytochemistry. J. Microscopy 143:139.
22. Clemens, M. J., A. G. Morris, and A. J. H. Gearing. 1987. Lymphokines and Interferons: A Practical Approach. IRL Press, Oxford.
23. Liew, F. Y., Y. Li, D. Moss, C. Parkinson, M. V. Rogers, and S. Moncada. 1991. Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur. J. Immunol. 21:3009.
24. Li, B., P. K. Sehajpal, A. Khanna, H. Vlassara, A. Cerami, K. H. Stenzel, and M. Suthanthiran. 1991. Differential regulation of transforming growth factor β and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction. J. Exp. Med. 174:1259.
25. Denich, K., P. Borlin, P. D. O'Hanley, M. Howard, and A. W. Heath. 1993. Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium: persistence and immune response in BALB/c mice and susceptibility to macrophage killing. Infect. Immun. 61:4818.
26. Nathan, C. P., and J. B. Hibbs, Jr. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65.
27. Green, S. J., and C. A. Nacy. 1993. Antimicrobial and immuopathologic effects of cytokine-induced nitric oxide synthesis. Curr. Opin. Infect. Dis. 6:384.
28. Wei, X., I. G. Charles, A. Smith, J. Ure, G. Feng, F. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408.
29. Vouldoukis, I., V. Riveros-Moreno, B. Dugas, F. Quaaz, P. Becherel, P. Debre, S. Moncada, and M. D. Mossalayi. 1995. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FcεRII/CD23 surface antigen. Proc. Natl. Acad. Sci. USA 92:7804.
30. Calandra, T., J. Bernhagen, R. A Mitchell, and R. Bucala. 1994. The macrophage is an important and previously unrecognised source of macrophage migration inhibitory factor. J. Exp. Med. 179:1895.
31. Bernhagen, J., M. Bacher, T. Calandra, C. N. Metz, S. B. Doty, T. Donnelly, and R. Bucala. 1996. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J. Exp. Med. 183:277.
32. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407.
33. Bogdan, C., H. Moll, W. Solbach, and M. Rollinghoff. 1990. Tumor necrosis factor-α in combination with interferon-gamma, but not with interleukin-4 activates murine macrophages for elimination of Leishmania major amastigotes. Eur. J. Immunol. 20:1131.
34. Liew, F. Y., Y. Li, S. Millott. 1990. Tumor necrosis factor alpha synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145:4306.